The Nifty Pharma index closed 1.18 per cent up at 13566.5.

“India is firing on most cylinders. There is a tremendous amount of infrastructure investment that is happening. It has been long overdue but we are now finally seeing it actually taking place, giving rise to a lot of business confidence. ”

On the technical charts, the 200-day moving average of the stock stood at Rs 146.36.

There was some volatility in the market given November futures and options contracts expired and traders rushed to either square their positions or roll over. The major reason behind the rally was buying in Reliance Industries shares.

“Limited downgrades over the last few quarters are a welcome change from almost given downgrades that we used to see after every quarterly results over the last 10 years.”

Real Estate Investment Trusts (REITs) offer an effective alternative. It can provide an improved diversification strategy for investors looking to re-allocate portions of their fixed income portfolio with an eye on a potential rise in interest rates.

As per the traders active in the unofficial market for unlisted shares, Tarson Products shares are trading at a premium of Rs 175-180, which is more than 27 per cent above the IPO price band of the company shares.

The stock quoted a 52-week high of Rs 1696.15 and a 52-week low of Rs 917.95.

As of 30-Sep-2021, promoters held 0.0 per cent stake in the company, while FIIs held 5.21 per cent and domestic institutional investors had 2.16 per cent.

"With the Reserve Bank of Australia more likely to hold a dovish stance on interest rates for quite some time, one can expect the greenback to strengthen further and the Australian dollar to remain under pressure", said Kunal Sawhney, chief executive officer of equity research firm Kalkine Group.